Search Page

1

Cite

Share

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s.

Oba T, Long MD, Keler T, Marsh HC, Minderman H, Abrams SI, Liu S, Ito F. Oba T, et al. Among authors: keler t. Nat Commun. 2020 Oct 27;11(1):5415. doi: 10.1038/s41467-020-19192-z. Nat Commun. 2020. PMID: 33110069 Free PMC article.

Cite

Share

2

Cite

Share

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.

Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Among authors: keler t. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.

Cite

Share

3

Cite

Share

High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization.

Alcántara-Hernández M, Leylek R, Wagar LE, Engleman EG, Keler T, Marinkovich MP, Davis MM, Nolan GP, Idoyaga J. Alcántara-Hernández M, et al. Among authors: keler t. Immunity. 2017 Dec 19;47(6):1037-1050.e6. doi: 10.1016/j.immuni.2017.11.001. Epub 2017 Dec 5. Immunity. 2017. PMID: 29221729 Free PMC article.

Cite

Share

4

Cite

Share

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

Caskey M, Klein F, Lorenzi JC, Seaman MS, West AP Jr, Buckley N, Kremer G, Nogueira L, Braunschweig M, Scheid JF, Horwitz JA, Shimeliovich I, Ben-Avraham S, Witmer-Pack M, Platten M, Lehmann C, Burke LA, Hawthorne T, Gorelick RJ, Walker BD, Keler T, Gulick RM, Fätkenheuer G, Schlesinger SJ, Nussenzweig MC. Caskey M, et al. Among authors: keler t. Nature. 2015 Jun 25;522(7557):487-91. doi: 10.1038/nature14411. Epub 2015 Apr 8. Nature. 2015. PMID: 25855300 Free PMC article. Clinical Trial.

Cite

Share

5

Cite

Share

Antibody-targeted vaccines.

Keler T, He L, Ramakrishna V, Champion B. Keler T, et al. Oncogene. 2007 May 28;26(25):3758-67. doi: 10.1038/sj.onc.1210375. Oncogene. 2007. PMID: 17530028 Review.

Cite

Share

6

Cite

Share

Mannose receptor-targeted vaccines.

Keler T, Ramakrishna V, Fanger MW. Keler T, et al. Expert Opin Biol Ther. 2004 Dec;4(12):1953-62. doi: 10.1517/14712598.4.12.1953. Expert Opin Biol Ther. 2004. PMID: 15571457 Review.

Cite

Share

7

Cite

Share

A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.

Oba T, Hoki T, Yamauchi T, Keler T, Marsh HC, Cao X, Ito F. Oba T, et al. Among authors: keler t. J Immunol. 2020 Oct 1;205(7):1867-1877. doi: 10.4049/jimmunol.2000347. Epub 2020 Aug 26. J Immunol. 2020. PMID: 32848036

Cite

Share

8

Cite

Share

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity.

Trumpfheller C, Longhi MP, Caskey M, Idoyaga J, Bozzacco L, Keler T, Schlesinger SJ, Steinman RM. Trumpfheller C, et al. Among authors: keler t. J Intern Med. 2012 Feb;271(2):183-92. doi: 10.1111/j.1365-2796.2011.02496.x. Epub 2012 Jan 4. J Intern Med. 2012. PMID: 22126373 Free PMC article. Review.

Cite

Share

9

Cite

Share

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies.

Ansell SM, Flinn I, Taylor MH, Sikic BI, Brody J, Nemunaitis J, Feldman A, Hawthorne TR, Rawls T, Keler T, Yellin MJ. Ansell SM, et al. Among authors: keler t. Blood Adv. 2020 May 12;4(9):1917-1926. doi: 10.1182/bloodadvances.2019001079. Blood Adv. 2020. PMID: 32380537 Free PMC article. Clinical Trial.

Cite

Share

10

Cite

Share

Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab.

Ramakrishna V, Sundarapandiyan K, Zhao B, Bylesjo M, Marsh HC, Keler T. Ramakrishna V, et al. Among authors: keler t. J Immunother Cancer. 2015 Aug 18;3:37. doi: 10.1186/s40425-015-0080-2. eCollection 2015. J Immunother Cancer. 2015. PMID: 26500773 Free PMC article.

Cite

Share